FDA approves generic Imitrex, Eloxatin from Sun

08/12/2009 | Reuters

Sun Pharmaceutical Industries obtained FDA clearance for its generic copies of GlaxoSmithKline's migraine drug Imitrex and Sanofi-Aventis' cancer drug Eloxatin. The Indian company said it will share a 180-day market protection for generic Eloxatin with three other drug firms.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ